Evaluation of the anti-tumour efficacy of Abemaciclib, a dual CDK4/6 inhibitor, both as a single agent and combined with radiotherapy in Medulloblastoma (2018)
Experts
Dr
Laura Genovesi
Honorary Senior Research Fellow
Institute for Molecular Bioscience
Senior Program Manager, Strategic Projects
Health Translation Queensland
Faculty of Health, Medicine and Behavioural Sciences
